BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27043610)

  • 1. Recombinant Pseudorabies Virus (PRV) Expressing Firefly Luciferase Effectively Screened for CRISPR/Cas9 Single Guide RNAs and Antiviral Compounds.
    Tang YD; Liu JT; Fang QQ; Wang TY; Sun MX; An TQ; Tian ZJ; Cai XH
    Viruses; 2016 Mar; 8(4):90. PubMed ID: 27043610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-mediated multiple single guide RNAs potently abrogate pseudorabies virus replication.
    Tang YD; Liu JT; Wang TY; Sun MX; Tian ZJ; Cai XH
    Arch Virol; 2017 Dec; 162(12):3881-3886. PubMed ID: 28900740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-based generation of a recombinant double-reporter pseudorabies virus and its characterization in vitro and in vivo.
    Fu PF; Cheng X; Su BQ; Duan LF; Wang CR; Niu XR; Wang J; Yang GY; Chu BB
    Vet Res; 2021 Jun; 52(1):95. PubMed ID: 34174954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudorabies virus can escape from CRISPR-Cas9-mediated inhibition.
    Peng Z; Ouyang T; Pang D; Ma T; Chen X; Guo N; Chen F; Yuan L; Ouyang H; Ren L
    Virus Res; 2016 Sep; 223():197-205. PubMed ID: 27507009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated pseudorabies virus developed using the CRISPR/Cas9 system.
    Tang YD; Liu JT; Wang TY; An TQ; Sun MX; Wang SJ; Fang QQ; Hou LL; Tian ZJ; Cai XH
    Virus Res; 2016 Oct; 225():33-39. PubMed ID: 27619840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and rapid approach to manipulate pseudorabies virus genome by CRISPR/Cas9 system.
    Xu A; Qin C; Lang Y; Wang M; Lin M; Li C; Zhang R; Tang J
    Biotechnol Lett; 2015 Jun; 37(6):1265-72. PubMed ID: 25724716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.
    Tang YD; Guo JC; Wang TY; Zhao K; Liu JT; Gao JC; Tian ZJ; An TQ; Cai XH
    FASEB J; 2018 Aug; 32(8):4293-4301. PubMed ID: 29509513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a US7/US8/UL23/US3-deleted recombinant pseudorabies virus and evaluation of its pathogenicity in dogs.
    Yin H; Li Z; Zhang J; Huang J; Kang H; Tian J; Qu L
    Vet Microbiol; 2020 Jan; 240():108543. PubMed ID: 31902487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a quadruple gene-deleted vaccine confers complete protective immunity against emerging PRV variant challenge in piglets.
    Sun L; Tang Y; Yan K; Zhang H
    Virol J; 2022 Jan; 19(1):19. PubMed ID: 35078501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Genome-Wide CRISPR/Cas9 Screen Reveals the Requirement of Host Sphingomyelin Synthase 1 for Infection with Pseudorabies Virus Mutant gD
    Hölper JE; Grey F; Baillie JK; Regan T; Parkinson NJ; Höper D; Thamamongood T; Schwemmle M; Pannhorst K; Wendt L; Mettenleiter TC; Klupp BG
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a recombinant classical swine fever virus stably expressing the firefly luciferase gene for quantitative antiviral assay.
    Shen L; Li Y; Chen J; Li C; Huang J; Luo Y; Sun Y; Li S; Qiu HJ
    Antiviral Res; 2014 Sep; 109():15-21. PubMed ID: 24956495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Pseudorabies virus vaccine developed using HDR-CRISPR/Cas9 induces strong humoral and cellular immune response in mice.
    Luo C; Wang Q; Guo R; Zhang J; Zhang J; Zhang R; Ma X; Wang P; Adam FEA; Zeshan B; Yang Z; Zhou Y; Wang X
    Virus Res; 2022 Dec; 322():198937. PubMed ID: 36174845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of CRISPR/Cas9 for Rapid Genome Editing of Pseudorabies Virus and Bovine Herpesvirus-1.
    Yu W; Liu J; Liu Y; Forlenza M; Chen H
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous recombination technology generated recombinant pseudorabies virus expressing EGFP facilitates to evaluate its susceptibility to different cells and screen antiviral compounds.
    Tan L; Shu X; Xu K; Liao F; Song C; Duan D; Yang S; Yao J; Wang A
    Res Vet Sci; 2022 Jul; 145():125-134. PubMed ID: 35190327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome editing of pseudorabies virus in the CRISPR/Cas9 era: a mini-review.
    Wang HM; Qiao YY; Cai BY; Tan J; Na L; Wang Y; Lu H; Tang YD
    Front Vet Sci; 2023; 10():1237186. PubMed ID: 37476821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graphene Oxide Nanoparticles Combined with CRISPR/Cas9 System Enable Efficient Inhibition of
    Li S; Sun Y; Du M; Shangguan A; Liu Z; Li W; Lina L; Liu W; Zhang S; Han H
    Bioconjug Chem; 2023 Feb; 34(2):326-332. PubMed ID: 36629744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV.
    Tong W; Zheng H; Li GX; Gao F; Shan TL; Zhou YJ; Yu H; Jiang YF; Yu LX; Li LW; Kong N; Tong GZ; Li JC
    Antiviral Res; 2020 Jan; 173():104652. PubMed ID: 31751590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Pathogenicity-Related Genes in the Current Pseudorabies Virus Outbreak in China.
    Tang YD; Liu JT; Wang TY; Sun MX; Tian ZJ; Cai XH
    Sci Rep; 2017 Aug; 7(1):7783. PubMed ID: 28798304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-Constructed Pseudorabies Virus Mutants Reveal the Importance of UL13 in Alphaherpesvirus Escape from Genome Silencing.
    Van Cleemput J; Koyuncu OO; Laval K; Engel EA; Enquist LW
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient transgene insertion in a pseudorabies virus vector by CRISPR/Cas9 and marker rescue-enforced recombination.
    Hübner A; Keil GM; Kabuuka T; Mettenleiter TC; Fuchs W
    J Virol Methods; 2018 Dec; 262():38-47. PubMed ID: 30248362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.